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ABSTRACT 
Objective: The purpose of this research was, synthesis of copper nanoparticles using environment friendly cementation method and evaluate their 
wound healing property on full-thickness excisional wound. 
Methods: Present study reports the synthesis of CNPs by single-step cementation method. Evaluation of CNPs was endorsed by morphological and 
chemical properties. Furthermore, CNPs was evaluated for its antibacterial potential and invitro hemocompatibility. Additionally, pharmacological 
evaluation of CNPs was assessed against excisional wound.  
Results: Characterization of final product indicate, particle size of CNPs were ranging from 100-150 nm. CNPs showed significant antibacterial 
activity (A= 2.1±0.1 mm, B =2.1±0.1 mm, C = 1.9±0.2 mm, at 10µg/ml), along with superior hemocompatibility (RBC cell survival 97±1 %). Further 
CNPs formulation shows increased level of anti-inflammatory cytokinin’s (IL-10, 42.7%) as compared to standard (STD), vehicle control, and 
normal control groups, attributed to accelerated wound healing (p<0.05 vs STD). 
Conclusion: The consequences the present investigation endorse the accelerated wound healing potential of CNPs with its anti-inflammatory potential. 
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INTRODUCTION 
Wound healing is a complex biological progression; wounding leads 
to tissue inflammation and the release of several pro-inflammatory 
cytokines including interferon-gamma (IFN-γ), interleukin [1] (IL-1), 
and tumor necrosis factors (TNF). The release of pro-inflammatory 
cytokines consequently recruits monocytes and macrophages [2]. 
Moreover, IFN-γ, TNF-α, and IL-1β lead to tissue apoptosis, because 
of the triggering of the innate immunity [3]. Wound healing requires 
a balance of micro-elements, matrix metalloproteinases, 
antioxidants, and other factors. Thus, over activation of pro-
inflammatory cytokines and obstructed instigation of anti-
inflammatory mediates delayed the healing rate of the wound [4]. 
Inhibition of the production of inflammatory cytokines, 
inflammatory transduction cascades, reduction of oxidative factors, 
and prevention of the microbial growth at the wound site may delay 
the healing rate [5]. Copper has an important role in the synthesis 
and stabilization of various skin proteins [6]. In addition, copper has 
been used against both gram-positive and gram-negative bacteria, 
fungi and vira [7]. Copper is traditionally known for its exceptional 
antibacterial and anti-inflammatory properties [8]. Moreover, 
copper enhances the rate of wound healing by providing optimum 
antibacterial and anti-inflammatory properties [9]. 
There is increase in the resistance to antibiotics and minimal anti-
inflammatory activity, limits the wound healing property of 
currently available agents [10]. Copper may be a promising 
therapeutic agent, as it has significant antibacterial, anti-
inflammatory, and wound healing potential [11]. However, copper 
deficiency is the common factor for impaired wound healing; copper 
nanoparticles (CNPs) having a particle size less than 33.8±0.3 nm 
have shown significant toxicity when compared to a 
nanoformulation of particle size 103±0.3 nm [12].  
MATERIALS AND METHODS 
Materials 
Copper nitrate was purchased from Central Drug House, New Delhi, 
India. Iron powder was purchased from Central Drug House, New 
Delhi, India. All other chemicals were of analytical grade, microbial 
culture escherichia coli (MTCC No. 1687), kocuria rhizophila (MTCC 
No. 1541) and staphylococcus aureus (MTCC No. 737) were obtained 
from CSIR-Microbial type culture collection and gene bank, 
Chandigarh, India. Formulation of 30 µg/ml of CNPs was suspended 
in 2% of Polyvinylpyrrolidone (PVP) solution and applied to wound 
exposed areas as treatment.  
Instrumentation 
Surface plasmon resonance was monitored using a UV-Visible 
spectrophotometer, Perkin Elmer LAMBDA 950 UV/Vis, operated 
between 800 to 200 nm wavelength ranges at room temperature. 
Copper ion concentration in the mother solution was determined by 
Atomic absorption spectroscopy, Perkin Elmer AA Spectrometers, 
AAnalyst 400. Fourier-transform infrared spectroscopy of the 
mother solution and nanoparticles was observed using the ALPHA II 
FTIR Spectrophotometer Bruker, USA. Hydrodynamic and stability 
of nanoparticles were determined by, Nanobook 90 plus, 
Brookhaven, USA and Malvern v2.3 Zeta potential analyser, USA. 
Morphological parameters were evaluated using, Scanning Electron 
Microscope, Zeiss Evo HD, Jena, Germany, and Transmission 
Electron Microscope, Morgagni 268D Fei Electron Optics, USA. 
Elemental analysis was done using EDS Oxford Instruments, UK. 
Morphology of the biological samples was done using an inverted 
microscope, Cosmo laboratory equipment, Ambala, India. The 
absorbance of immunological samples was evaluated using Erba Lisa 
Scan EM, Transasia Bio-Medicals Ltd. India. 
Preparation of copper nanoparticles 
CNPs were prepared using a cementation process. An iron plate 
having a surface area of 1 cm2 is placed in a freshly prepared 
solution of copper nitrate at 70 ⁰C for 120 min. Freshly prepared 
nanoparticles were centrifuged at 11700 Relative Centrifugal Force 
(RCF) for 15 min. The supernatant was discarded, and the 
nanoparticles were resuspended in fresh distilled water by 
sonification. This process was repeated until a clear supernatant 
solution was obtained. Finally, 2% PVP was added to freshly 
prepared nanoparticles suspension to prevent the formation of 
larger size nanoparticles by agglomeration of nanoparticles. 
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SPR studies 
Surface plasmon resonance (SPR) of the prepared nanoparticles was 
obtained, to evidence the formation of CNPs. The freshly cleaned 
iron plate having the surface area of 1 cm2was placed in a freshly 
prepared solution of copper nitrate 0.001 M in ultrapure Millipore 
water at 70 ⁰C. The solution was ultrasonicated, to dislodge freshly 
prepared CNPs. The sample was withdrawn and measured against 
the solution of 0.001 M copper nitrate solution [13]. 
AAS studies 
Atomic absorption spectroscopy (AAS) helped, in the determination 
of the amount of CNPs formed at a specific time interval. An iron 
plate having a surface area of 1 cm2 was added to the 10 ppm 
solution of copper nitrate at 70 ⁰C and ultrasonicated for 5 min. 
Periodic sampling was done (0, 10, 20, 30, 60 and 120 min) and 
filtered using a syringe filter (0.1 μm), to remove synthesized CNPs. 
The amount of copper ions presents in the mother solution was 
observed, to determine the completion of the reaction [14]. 
FTIR studies 
Fourier-transform infrared spectroscopy (FTIR) technique was used, 
to observe the emission of vibrational frequency emitted by 
resonating molecules. The samples were mixed with potassium 
bromide and pressed with a high-pressure hydraulic press for pallet 
formation, to obtain FTIR spectra [15]. 
DLS studies 
Dynamic light scattering (DLS) was used to determine the particle 
size distribution of the prepared CNPs. A freshly prepared sample (5 
ml) was resuspended by ultrasonication and particle size 
distribution was measured [16]. 
Zeta studies 
Zeta Potential was used to determine the surface charge of the 
formulation. Freshly prepared sample (5 ml) was resuspended by 
ultrasonication and measured using a zetasizer [17]. 
SEM studies 
Scanning electron microscopy (SEM) was used to evaluate the surface 
morphology of the prepared nanoparticles. The sample was 
resuspended in distilled water and ultrasonicated. One drop of CNPs 
suspension was air-dried on a glass slide (1x1 cm2) and gold-coated [18]. 
TEM studies 
The morphology of the prepared nanoparticle section with particle size 
was studied by transmission electron microscopy (TEM). Samples were 
analyzed using carbon-coated TEM mesh grids of 400 mesh [19]. 
Elemental studies 
Energy-dispersive X-ray spectroscopy (EDS) was done by the freshly 
resuspended sample and was air-dried on a glass slide of 1 cm2 area. 
With the help of SEM, the specific area was selected, and X-ray 
dispersion of specific regions was observed. X-ray radiation was 
bombarded on the surface of prepared nanoparticles. The radiation 
emitted by the CNPs was observed to evaluate the elemental 
composition [20]. 
Study of antibacterial property 
Kirby-Bauer disk diffusion susceptibility CNPs was done to evaluate 
the antibacterial property of synthesized nanoparticles. Suspension 
of prepared nanoparticles was prepared and tested against standard 
(STD) solution of amoxicillin 10 µg/ml and evaluated against CNPs 
suspension 10, 120, and 30 µg/ml. Zone of inhibition was noted and 
compared against STD at the 12th hr of incubation 37 ℃ in Luria 
broth medium [21]. 
Hemagglutinin assay 
The biocompatibility of CNPs was studied using the Hemagglutinin 
assay. About one ml of fresh blood was collated from animals and 
centrifuged at 5488 RCF (4 ⁰C, 10 min). Supernatant was discarded, 
and the pallet was resuspended in 60 ml of normal saline. One ml 
the prepared solution was added (1:1) to STD (Triton X-100) and 
CNPs sample and incubated at 37 ⁰C for 1 hr. Smear of Normal Saline 
(normal control; NC), triton X-100 (Positive control; PC) and, CNPs 
samples were observed under optical microscope [22]. 
RBC cell viability assay 
To evaluate the in vitro biocompatibility of synthesized CNPs was 
evaluated by haemolysis assay. Fresh blood was collated from 
Albino wistar rats, through the retro orbital puncture. Suspension of 
CNPs and STD (Triton X-100) were added to an equal amount (100 
µl) of uncoagulated blood sample and incubated in a CO2 incubator 
(37 ⁰C, 95% RH) for 1hr. The absorbance was taken at 450 nm and 
the haemolytic rate was calculated as:  
100 −  {(SA − NCA)/(PCA − NCA) × 100} 
Where SA is sample absorbance, NCA is negative control absorbance, 
PCA is positive control absorbance [23]. 
Animal maintenance 
Wistar rats of either sex and weight of 230-250g were used for the 
present study. All animal experiments were approved by the 
Institutional animal ethics committee (IAEC), Amity University, A-Block, 
Noida (approval number: CPCSEA/IAEC/AIP/2016/04/13). The animals 
were first acclimatized in the institutional animal experimental room 
(temp 20±2 ⁰C, 60±10 Humidity) at normal day and night cycle for 7 d. 
All animals were maintained on rat chow and water ad libitum. 
Creation of full-thickness excision wound  
Animals were anesthetized by intraperitoneal administration of 
ketamine and xylazine (80 and 10 mg/kg respectively). The dorsal 
area of the rats was shaved and wiped with a 10 % povidone-iodine 
solution. On the first day of the experiment, aseptically single wound 
was created using biopsy punch in each rat with a diameter of 15 
mm at the interscapular region of the rat dorsal area. Epithelial 
wounds were covered with a non-woven polyester dressing (3M 
Dressing Cover Medipore NonWoven Polyester) [24]. 
Estimation of epithelization period 
The wound epithelialization period was determined by measuring 
the wound contraction using Vernier Caliper. The epithelization 
period was measured with the help of the wound contraction rate, 
which is expressed below. 
% wound contraction rate 
=  
(Initial wound diameter − Wound diameter at speci�ic day)
Initial wound diameter
 X 100 
Histological evaluation  
Three rats from each group were sacrificed on the 5th and 13th day 
of the experiment. Sections of wounds were used for histological 
evaluation. The histological sections were evaluated using 
hematoxylin and eosin staining for measuring re-epithelization, 
fibroblast accumulation, polymorphonuclear leukocytes, and 
collagen formation using an inverted light microscope [25].  
Estimation of inflammatory cytokines 
The wound healing rate depends on the delicate balance between 
pro-inflammatory (IL-6, TNF-α) and anti-inflammatory (IL-10) 
cytokinins. The blood samples were collected on the 5th and 13th 
day and serum were separated, respectively. The concentration of 
IL-6, TNF-α and IL-10 were evaluated using enzyme-linked 
immunoassay ELISA, Ray Biotech, USA [26]. 
Statistical analysis 
All the values were expressed in mean±SD. All data of biochemical 
parameters were statistically analyzed using one-way ANOVA, followed 
by Tukey post-hoc (SigmaPlot V12, Systat Software Inc. California, USA). 
RESULTS 
SPR studies 
The copper ions (Cu2+) present in the solution of copper nitrate 
gets reduced to elemental copper (Cu°). The free-electron 
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presents on the surface of freshly prepared CNPs showed the 
resonance peak at 350-400 nm (fig. 1), indicating the presence of 
CNPs [13]. 
AAS studies 
The reduction of Cu2+ions to Cu° confirms the synthesis of CNPs (fig. 
1). AAS indicated the decrease in the concentration of Cu2+ions, 
which have been reduced to Cu° by elemental iron. The decrease in 
the rate of conversion of Cu2+to Cu ° indicates the completion of the 
reaction.  
FTIR studies 
FTIR is an emission spectrum of copper nitrate and CNPs indicate 
the characteristic frequency band of ferric nitrate complex at 1629 
cm-1 (fig. 1), which indicates the successful reduction of copper ions 
into elemental copper by iron resulting in ferric nitrate as product 
formation, confirming CNPs synthesis [13].  
DLS studies 
The graph obtained by DLS indicates the particle size of the formulation 
in the range of 80 to 150 nm, with a mean effective diameter of 105 nm 
(fig. 1). The single peak presence showed uniformly sized nanoparticles, 
indicating good quality of formulation [16]. 
Zeta studies 
The zeta potential of the formulation was found to 33.11±2 mV (fig. 
1), which is above to the minimum required surface charge potential 
of±30 mV for the particle size of 100 nm to overcome the 
gravitational attraction force to prevent sedimentation and 
glomerular formation, which may increase the size of CNPs [27]. 
 
 
Fig. 1: (A) SPR of CNPs was studied by observing UV-Visible absorption spectra during the synthesis of CNPs. (B) AAS flame spectra of 
CNPs, show the conversion of ionic copper ions into CNPs. (C) FTIR spectra of copper nitrate and CNPs mother solution, indicating 
formation of ferric nitrate. (D) DLS spectra of CNPs indicating a hydrodynamic radius of less than 105±2. (E) Zeta potential of CNPs 
indicating surface charge 33.11±2 mV 
 
 
Fig. 2: (A) SEM of CNPs showing particle size of less than 100 nm. (B) TEM of CNPs showing particle size less than 100 nm. (C) EDX of CNPs 
indicating the presence of copper in CNPs 
 
SEM studies 
SEM was done on the electron beam strength of 10.00kV at 51.90K X 
magnification. The morphological evaluation (fig. 2) showed the 
spherical (uniformly created) nanoparticles having a particle size of 
less than 100 nm.  
TEM studies 
TEM scanning of the sample was done with 150K X 
magnification. The particle size of the prepared nanoparticles 
was found to be less than 100 nm (fig. 2), ensuring the non-
toxicity of CNPs. 
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Elemental studies 
EDX spectroscopy confirms the presence of the high amount of 
copper and trace amount of oxygen, indicating very little oxidation 
of the outer layer of CNPs (fig. 2). The rest of the peak indicates the 
presence of other elements like Gold and silicon, which may be due 
to the gold coating of samples for electron microscopy and the base 
plate is made of silicon glass [20]. 
Study of antibacterial property 
The samples were evaluated using Kirby-Bauer disk diffusion 
methods. Disk loaded with the CNPs and STD formulation was 
placed on the culture medium of different microorganisms, the zone 
of inhibition of CNPs formulation was compared against STD 




Fig. 3: Kirby-bauer disk diffusion susceptibility studies against (A) Staphylococcus aureus, (B) Kocuria rhizophila, (C) Escherichia coli, to 
evaluate the zone of inhibition of different concentration of CNPs was compared to STD formulation. (D) shows the zone of inhibition of 
STD and CNPs (10-30 µg/ml). All values are expressed as, n = 3, mean±SD 
 
 
Fig. 4: Biocompatibility studies of CNPs was done by hemocompatibility study (A) shows a microscopic image of STD, (B) NC, (C) CNPs 
formulation, (D) shows the rate of RBC cell viability of CNPs as compared to normal saline (NS) and, triton X-100. All values are expressed 
as, n = 6, mean±SD. a =p<0.05 vs positive control 
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Hemagglutinin assay 
Hemagglutinin assay helps to determine the change in morphology 
of RBCs after exposure to prepared nanoparticles. The blood 
aggregation was evaluated against untreated RBC in normal saline 
consisting of biconcave shaped RBCs cells. The CNPs treated RBCs 
(fig. 4 A, B, and C) showed no significant hemagglutination indicating 
high biocompatibility [28]. 
RBC cell viability assay 
RBC cell viability assay helps in the determination of 
biocompatibility of prepared nanoparticles. The CNPs treated RBCs 
samples were evaluated against the STD suspension of RBC in 
normal saline solution. Hemolysis assay (fig. 4D) indicated no 
significant hemolysis, resulting in no significant free hemoglobin in 
the supernatant solution. The rate of hemolysis was found in an 
acceptable range of less than 5 % [22]. 
Wound healing study 
Single full-thickness wounds of 15 mm diameter were created on all 
animals, showing significant variation in the initiation and 
completion of wound healing study. On 5th and the 13th day of the 
study indicated important phases of wound healing and were 
selected for evaluation of histological sections and biochemical 
parameters. The percentage of wound closure was measured until 
full closure was obtained in all animals. The percentage of wound 
closure was expressed in fig. 5, indicating accelerated wound healing 
in different groups as compared to the control group.  
On the 5th day, the percentage wound contraction of the CNPs group 
was significantly more as compared to the untreated group (20.18 % 
and 7.72 % respectively). Similarly, on the 13th day, the wound 
contraction of the CNPs group was 100 %, indicating full recovery, 
which is significantly higher as compared to other groups, including 
NC, vehicle control (VC) and STD group [23]. 
Histology analysis 
Histological assessment in fig. 6, of burn tissue at the end of the 
study protocol revealed the presence of various proinflammatory 
cytokines. The tissue of NC, VC, and STD control group shows the 
presence of exudate, leukocyte infiltration, collagen deposition, and 
incomplete re-epithelization. Whereas the histogram of treatment 
group tissue shows comparatively low exudate and collagen 
deposition. Moreover, the treatment group shows, complete re-
epithelialization, which confirms the accelerated wound healing 
potential of treatment [29]. 
 
 
Fig. 5: Healing rate of wound by CNPs was studied, (A) physical observation of wound on day 0, (B) day 5, (C) day 13. (D) shows the 
percentage wound contraction of the group, NC, VC, STD, and CNPs on day 5th. (E) shows the percentage wound contraction of group, NC, 
VC, STD, and CNPs on day 11th. (F) shows the percentage wound closure of group NC, VC, STD, and CNPs. All values are expressed as, n = 6, 
mean±SD. a =p<0.05 vs NC 
 
 
Fig. 6: (A) Histological evaluation at the wound site of different groups (400X) on the 13th day of post-treatment. The presence of 
leukocyte infiltration, exudate, collagen deposition and re-epithelization was indicated by red, yellow, white and blue arrows, 
respectively. (B) concentration of IL-10, (C) concentration of TNF-α, (D) concentration of IL-6 on respective groups (NC, STD, VC, CNPs) on 
the 5th and 13th day. All values are expressed as, n = 6, mean±SD. * =p<0.05 vs. NC, # =p<0.05 vs STD 
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Inflammatory parameters 
Evaluation of pro-inflammatory and anti-inflammatory cytokines 
supports the result of histological analysis. In fig. 6, the serum IL-6, 
TNF-α, and IL-10 were done on the 5th and 13th day of study. The 
evaluation indicated a significantly lower level of pro-inflammatory 
cytokines (IL-6, 34.6 % and TNF-α, 51.8%) in CNPs formulation 
treated groups as compared to the NC group [30). On the other hand, 
an inversely significant higher concentration of anti-inflammatory 
cytokinin’s (IL-10, 42.7%) indicated the effectiveness of CNPs for 
promoting the formation of anti-inflammatory cytokinin’s [31]. A 
similar trend was obtained on the 13th day, where the concentration 
of IL-6 and TNF-α was significantly reduced in the CNPs group, as 
compared to the NC group (35.2% and 53.4 %). Moreover, the 
concentration of IL-10 was reduced, which indicates faster 
neutralization of the inflammatory phase by CNPs. 
Wound contraction 
The wound contraction study on the 5th day indicated significant 
wound contraction (16.00 %) as compared to NC, while the wound 
contraction in VC and STD groups was not much significant as 
compared to NC. On the 13th day, a similar trend was followed. The 
wound contraction rate of CNPs formulation (85.03 %) was 
significant as compared to the NC group (37.33 %), which supports 
the findings of histological analysis, indicating superior wound 
healing on CNPs (fig. 5). The wound contraction rate study supports 
the results of the inflammatory cytokines study, indicating the 
promotion of wound healing and the CNPs helps in acceleration of 
the wound healing process [32]. The wound diameter was observed 
on both axes in triplicate to determine the wound contraction rate. 
The wound contraction rate of CNPs formulation has shown 
significant contraction, as compared to the NC group and STD group. 
The rate of contraction of VC was not significant, as compared to no 
treatment group. The slight faster wound healing in the STD group, 
as compared to NC and VC group was due to the humectant property 
of the STD formulation. 
DISCUSSION 
After induction of wound injury homeostasis, the inflammatory 
response kicks-in to release cytokines growth factors and 
chemoattractants to lure lymphocytes and macrophages to the 
wound site. 
Cytokines promote fibroblast migration resulting in endothelial cell 
proliferation. Fibroblasts release collagen, proteoglycans and 
glycosaminoglycans, to create the extracellular matrix [33]. The re-
epithelization phase is the rate-limiting phase in the wound healing 
process [29]. The feature of the chronic wound includes a 
prolongation of the inflammatory phase, with profuse leukocyte 
infiltration, reduced cellular signaling and fibroblast proliferation.  
Attuning pro and anti-inflammatory cytokines is essential for 
accelerated wound healing. In the present work, we have formulated 
novel CNPs and evaluated wound healing activity with respect to 
attuning the inflammatory phases, resulting in the remodeling of 
excision wound [5]. Our results showed the synthesis of CNPs from 
copper nitrate solution by the novel cementation method, with 
particle size in the range of 100-150 nm. The in vitro wound healing 
assay shows faster-wound healing activity significantly as compared 
to the control group. Further, faster wound healing was observed in 
the treated groups with topical application of CNPs formulation. 
CNPs formulation shows best results among all formulations, among 
all the formulation levels of IL-6, TNF-∝ levels were observed on 5th 
and the 11th-day slight increment in levels of IL-10 was observed in 
case of STD and VC group and significant increment in CNPs group. 
In CNPs treated group, there is a rapid decrease in levels of pro-
inflammatory and anti-inflammatory cytokines, indicating 
accelerated wound healing, also in CNPs treated group there is a 
faster deposition of collagens and accelerated re-epithelization was 
observed. CNPs have also shown to reduce the microbial load and 
consequently endorse the fast healing of wounds. CNPs show 
significantly higher wound healing as compared to other groups due 
to anti-inflammatory activity. Moreover, plausible development of 
alternatives, this formulation holds strong potential to be explored 
for the treatment of chronic non-healing wounds, including burns 
due to heat, chemical and radiation-induced burn wounds.  
CONCLUSION 
Consequences of the present investigation conclude that, the formation 
of copper nanoparticles by the cementation method has a significant 
purity, with the desirable morphological characteristic of nanoparticles. 
Copper nanoparticles show significant antibacterial potential, which 
probably leads to its antimicrobial property that accelerates the wound 
healing rate. Moreover, the treatment of copper nanoparticles endorses 
significant wound healing with anti-inflammatory potential, which were 
confirmed by the assessment of various inflammatory biomarkers. Thus, 
the study enlightens the therapeutic potential of copper nanoparticles 
against wound injury by resisting bacterial contamination and significant 
regulation in inflammatory biomarkers, which may be endorsed as an 
underlying mechanism. 
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